A publication referencing bremelanotide was released on May 22, 2026. The publication, titled "Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov," appeared in Frontiers in Medicine.
The publication is described as a systematic review and analysis of completed studies registered on ClinicalTrials.gov, focused on pharmacological therapies for hypoactive sexual desire disorder in women. Bremelanotide is an approved compound included within the scope of this review.
No specific findings, outcomes, or conclusions from the review have been provided beyond its title, journal, and publication date. This brief reports only that the publication exists and its stated scope, without summarizing or interpreting any results.
Readers interested in the approved status and background of bremelanotide can consult the compound overview for additional context.